URMC / Research / Health Research /Clinical Trials / Study Details

PBRN00002 / ANBL00B1 / Kazi

Research Question:
Can doctors identify biomarkers, a measurable substance in tissues that may predict disease, in patients with neuroblastoma or ganglioneuroblastoma?

Basic Study Information

Purpose:
This research trial studies biomarkers in tumor tissue samples from patients with newly diagnosed neuroblastoma or ganglioneuroblastoma. Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer.

Location: University of Rochester

Lead Researcher (Principal Investigator)

Lead Researcher: Rafi Kazi

Study Contact Information

Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email: WCICTOResearch@urmc.rochester.edu

Additional Study Details

Contact This Study

First Name *

This field is required

Middle Name

Last Name *

This field is required

Phone Number

I agree to be contacted by The University of Rochester Medical Center regarding participation in this study. *

You must agree to be contacted to continue.

Please call me during the day.

Please call me during the evening.

Message

Return to Search

Research

UR Health Research